BSX

Boston Scient
NYSE

Real-time Quotes | Nasdaq Last Sale

31.05
+0.86
+2.85%
After Hours: 31.05 0 0.00% 16:34 04/02 EDT
OPEN
30.01
PREV CLOSE
30.19
HIGH
31.46
LOW
29.65
VOLUME
12.40M
TURNOVER
--
52 WEEK HIGH
46.62
52 WEEK LOW
24.10
MARKET CAP
43.45B
P/E (TTM)
9.33
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BSX stock price target is 46.87 with a high estimate of 58.00 and a low estimate of 35.00.

EPS

BSX News

More
  • Coronavirus update: 981,221 global cases, 50,230 deaths and U.S. workers file for benefits in record numbers
  • MarketWatch · 5h ago
  • Boston Scientific cuts exec pay as revenue slides
  • American City Business Journals · 5h ago
  • Needham Maintains Buy on Boston Scientific, Lowers Price Target to $43
  • Benzinga · 8h ago
  • Boston Scientific Sees More Revenue Doom and Gloom in Second Quarter
  • SmarterAnalyst · 11h ago

Industry

Advanced Medical Equipment & Technology
+4.07%
Healthcare Equipment & Supplies
+3.33%

Hot Stocks

Symbol
Price
%Change

About BSX

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.
More

Webull offers kinds of Boston Scientific Corporation stock information, including NYSE:BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions.